DeepoMe

DeepoMe is a German health-tech company that utilizes deep phenotyping and artificial intelligence to transform the diagnosis and treatment of metabolic disorders. The company's proprietary platform analyzes complex metabolomic data to provide high-resolution insights into an individual's metabolic state, enabling early detection and personalized intervention strategies. Focused initially on type 2 diabetes and metabolic syndrome, DeepoMe aims to improve patient outcomes through precision medicine. By integrating clinical data with advanced molecular profiling, the company supports healthcare providers in making data-driven decisions for chronic disease management. The technology is a spin-off from the University of Tübingen and the German Center for Diabetes Research (DZD).